71 related articles for article (PubMed ID: 23961831)
1. Investigation of the rat model for preclinical evaluation of pH-dependent oral absorption in humans.
Lubach JW; Chen JZ; Hau J; Imperio J; Coraggio M; Liu L; Wong H
Mol Pharm; 2013 Nov; 10(11):3997-4004. PubMed ID: 23961831
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and absorption of the anticancer agents dasatinib and GDC-0941 under various gastric conditions in dogs--reversing the effect of elevated gastric pH with betaine HCl.
Pang J; Dalziel G; Dean B; Ware JA; Salphati L
Mol Pharm; 2013 Nov; 10(11):4024-31. PubMed ID: 23980865
[TBL] [Abstract][Full Text] [Related]
3. pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model.
Zhou R; Moench P; Heran C; Lu X; Mathias N; Faria TN; Wall DA; Hussain MA; Smith RL; Sun D
Pharm Res; 2005 Feb; 22(2):188-92. PubMed ID: 15783065
[TBL] [Abstract][Full Text] [Related]
4. Prediction of pH dependent absorption using in vitro, in silico, and in vivo rat models: Early liability assessment during lead optimization.
Saxena A; Shah D; Padmanabhan S; Gautam SS; Chowan GS; Mandlekar S; Desikan S
Eur J Pharm Sci; 2015 Aug; 76():173-80. PubMed ID: 25960252
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of the effect of gastric acid pH modulators on the bioavailability of oral dasatinib in healthy subjects.
Eley T; Luo FR; Agrawal S; Sanil A; Manning J; Li T; Blackwood-Chirchir A; Bertz R
J Clin Pharmacol; 2009 Jun; 49(6):700-9. PubMed ID: 19395585
[TBL] [Abstract][Full Text] [Related]
6. Improved dissolution and absorption of ketoconazole in the presence of organic acids as pH-modifiers.
Adachi M; Hinatsu Y; Kusamori K; Katsumi H; Sakane T; Nakatani M; Wada K; Yamamoto A
Eur J Pharm Sci; 2015 Aug; 76():225-30. PubMed ID: 25988287
[TBL] [Abstract][Full Text] [Related]
7. Development of a canine model to enable the preclinical assessment of pH-dependent absorption of test compounds.
Fancher RM; Zhang H; Sleczka B; Derbin G; Rockar R; Marathe P
J Pharm Sci; 2011 Jul; 100(7):2979-88. PubMed ID: 21254068
[TBL] [Abstract][Full Text] [Related]
8. Using absorption simulation and gastric pH modulated dog model for formulation development to overcome achlorhydria effect.
Mitra A; Kesisoglou F; Beauchamp M; Zhu W; Chiti F; Wu Y
Mol Pharm; 2011 Dec; 8(6):2216-23. PubMed ID: 21981752
[TBL] [Abstract][Full Text] [Related]
9. Ketoconazole ion-exchange fiber complex: a novel method to reduce the individual difference of bioavailability in oral administration caused by gastric anacidity.
Xin C; Li-hong W; Jing Y; Yang Y; Yue Y; Qi-fang W; San-ming L
Pharm Dev Technol; 2013; 18(6):1346-54. PubMed ID: 22670853
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the GI transit conditions in Beagle dogs with a telemetric motility capsule.
Koziolek M; Grimm M; Bollmann T; Schäfer KJ; Blattner SM; Lotz R; Boeck G; Weitschies W
Eur J Pharm Biopharm; 2019 Mar; 136():221-230. PubMed ID: 30703546
[TBL] [Abstract][Full Text] [Related]
11. Effects of Manufacturing Methods on Dissolution and Absorption of Ketoconazole in the Presence of Organic Acid as a pH Modifier.
Adachi M; Hinatsu Y; Kusamori K; Katsumi H; Sakane T; Nakatani M; Wada K; Yamamoto A
AAPS PharmSciTech; 2017 May; 18(4):1203-1212. PubMed ID: 27431914
[TBL] [Abstract][Full Text] [Related]
12. Utilization of In Vitro, In Vivo and In Silico Tools to Evaluate the pH-Dependent Absorption of a BCS Class II Compound and Identify a pH-Effect Mitigating Strategy.
Gesenberg C; Mathias NR; Xu Y; Crison J; Savant I; Saari A; Good DJ; Hemenway JN; Narang AS; Schartman RR; Zheng N; Buzescu A; Patel J
Pharm Res; 2019 Oct; 36(12):164. PubMed ID: 31637544
[TBL] [Abstract][Full Text] [Related]
13. Influence of gastric acid on gastric emptying and gastric distension-induced pain response in rats--effects of famotidine and mosapride.
Keto Y; Hirata T; Takemoto Y; Yamano M; Yokoyama T
Neurogastroenterol Motil; 2012 Feb; 24(2):147-53, e88. PubMed ID: 22066725
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Gastric pH on the Pharmacokinetics-pharmacodynamics of Naphthoquine in Rodents, as well as in Human Predicted Using a PBPK Model.
Xie Y; Liu H; Chen X; Xing J
Curr Drug Metab; 2021; 22(5):363-371. PubMed ID: 33511926
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Dissolution of Fluconazole and Dipyridamole in Gastrointestinal Simulator (GIS), Predicting in Vivo Dissolution and Drug-Drug Interaction Caused by Acid-Reducing Agents.
Matsui K; Tsume Y; Amidon GE; Amidon GL
Mol Pharm; 2015 Jul; 12(7):2418-28. PubMed ID: 25985298
[TBL] [Abstract][Full Text] [Related]
16. pH-dependent oral absorption of L-735,524, a potent HIV protease inhibitor, in rats and dogs.
Lin JH; Chen IW; Vastag KJ; Ostovic D
Drug Metab Dispos; 1995 Jul; 23(7):730-5. PubMed ID: 7587962
[TBL] [Abstract][Full Text] [Related]
17. Influence of H2-receptor antagonists and proton pump inhibitors on dasatinib pharmacokinetics in Japanese leukemia patients.
Takahashi N; Miura M; Niioka T; Sawada K
Cancer Chemother Pharmacol; 2012 Apr; 69(4):999-1004. PubMed ID: 22147077
[TBL] [Abstract][Full Text] [Related]
18. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
Kamath AV; Wang J; Lee FY; Marathe PH
Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
[TBL] [Abstract][Full Text] [Related]
19. Co-administration of a nanosuspension of a poorly soluble basic compound and a solution of a proton pump inhibitor--the importance of gastrointestinal pH and solubility for the in vivo exposure.
Sigfridsson K; Lundqvist A; Strimfors M
Drug Dev Ind Pharm; 2011 Sep; 37(9):1036-42. PubMed ID: 21417620
[TBL] [Abstract][Full Text] [Related]
20. Glyceride derivatives as potential prodrugs: synthesis, biological activity and kinetic studies of glyceride derivatives of mefenamic acid.
Khan MS; Akhter M
Pharmazie; 2005 Feb; 60(2):110-4. PubMed ID: 15739898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
